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Abstract: (1) Objective: The World Health Organization’s (WHO) International Classification of
Functioning, Disability and Health (ICF) classification is a unified framework for the description of
health and health-related states. This study aimed to use the ICF framework to classify outcome
measures used in follow-up studies of coronavirus outbreaks and make recommendations for future
studies. (2) Methods: EMBASE, MEDLINE, CINAHL and PsycINFO were systematically searched
for original studies assessing clinical outcomes in adult survivors of severe acute respiratory distress
syndrome (SARS), middle east respiratory syndrome (MERS) and coronavirus disease-19 (COVID-19)
after hospital discharge. Individual items of the identified outcome measures were linked to ICF
second-level and third-level categories using ICF linking rules and categorized according to an ICF
component. (3) Results: In total, 33 outcome measures were identified from 36 studies. Commonly
used (a) ICF body function measures were Pulmonary Function Tests (PFT), Impact of event scale
(IES-R) and Hospital Anxiety and Depression Scale (HADS); (b) ICF activity was 6-Minute Walking
Distance (6MWD); (c) ICF participation measures included Short Form-36 (SF-36) and St George’s
Respiratory Questionnaire (SGRQ). ICF environmental factors and personal factors were rarely
measured. (4) Conclusions. We recommend future COVID-19 follow-up studies to use the ICF
framework to select a combination of outcome measures that capture all the components for a better
understanding of the impact on survivors and planning interventions to maximize functional return.
Keywords: COVID-19; SARS; MERS; outcome measures; follow-up studies; prevalence; lung function;
exercise tolerance; mental health; quality of life
1. Introduction
Coronavirus disease 2019 (COVID-19) has posed a major challenge to healthcare systems
worldwide, with over 6 million confirmed cases and 350,000 deaths reported as of May 2020 [1].
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Whilst current efforts have been duly focused on reducing mortality, issues regarding potential
long-term complications in COVID-19 survivors are starting to emerge [2–4]. In the previous
coronavirus outbreaks of severe acute respiratory syndrome (SARS) and Middle East respiratory
syndrome (MERS), such long-term sequelae spanned across the physical, psychological and social
domains of health [5,6]. Early reports of COVID-19 follow-up studies are suggestive of prevalence
of similar health problems in COVID-19 survivors as those reported in previous outbreaks of SARS
and MERS [7,8]. Considering the multi-systemic impact of COVID-19, follow-up studies across all
these domains of health are required in order to truly understand these individuals’ experiences and
support their return to societal roles.
Post-acute early rehabilitation of coronavirus survivors would foremost involve recovery of
body structure and function. Impairment of respiratory function [9–11], exercise tolerance [12] and
neuromuscular functions [13] have been reported to be present in coronavirus survivors beyond
3 months post-infection, with improvement to some degree in many of these individuals. However,
improvement in these impairments of body structure and function may not necessarily translate into
recovery from disability and role limitation [14,15]. For instance, during the SARS outbreak in 2002,
even though most patients had good recovery from their physical illness, their quality of life was still
lower than healthy individuals and as many as 17% of coronavirus survivors had not returned to work
1-year post-discharge [11]. Furthermore, evaluation of impairment without the knowledge of personal
factors and help available to them in their environments can be futile as barriers in these contextual
factors need to be overcome to facilitate participation of the individual in society.
In order to assess survivors’ long-term health comprehensively and provide rehabilitation,
all aspects of health that influence recovery, including organ impairments, functional limitations
and personal circumstances, should be assessed. The World Health Organization’s International
Classification of Functioning, Disability and Health (WHO ICF) model put forward in 2001 provides a
coherent view of different aspects of health from biological, individual and social perspectives [16,17].
This framework has been extensively researched and validated for describing health state [17],
epidemiology [18] and public health [18], classifying outcome measures [15,19] and planning
interventions [16,20]. The interplay between these factors in COVID-19 survivors is important
to recognize in order to characterize their multi-systemic problems and disability and improve
“functioning” by targeted interventions.
The aim of this systematic review is to identify outcome measures which have been used in
follow-up studies in the coronavirus outbreaks, including SARS in 2002 and MERS in 2012 [21], and to
classify them using the ICF model. This will allow an understanding of whether all aspects of the
health condition have been captured by these studies and highlight any gaps that need to be considered
when selecting outcome measures for future studies.
2. Methods
This systematic review was conducted in two stages.
2.1. Stage 1. Identification of Long-Term Follow-Up Studies in Survivors of Previous Coronavirus Outbreaks
A comprehensive search of 4 databases, MEDLINE (1946 to Week 1 May 2020), EMBASE (1974 to
8th May 2020), CINAHL Plus (1937 to Week 1 May 2020) and PsycINFO (1806 to Week 1 May 2020),
was performed. The search strategy used was [(Coronavirus OR Coronavirus Infections OR COVID OR
SARS virus OR Severe acute respiratory syndrome OR MERS OR Middle east respiratory syndrome)
AND (Follow-up OR Follow-up studies OR Prevalence)]. Terms were entered as MeSH terms where
available for each database; otherwise, these were searched as keywords in the title, abstract and
subject headings.
The searches were first screened using the abstract and then using the full text by two independent
authors based on the inclusion and exclusion criteria below. Original studies involving adults with
confirmed diagnosis of coronavirus infection who were followed up for any period post-discharge
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were included. Further inclusion was limited to studies that used at least one clinical outcome measure
during the follow-up (e.g., studies investigating mortality only were excluded). Reviews, case reports
and editorial reports were excluded. Information regarding the authors, study year and outcome
measures used in all the included studies was extracted into standardized tables. Extraction was
undertaken by KP and MS independently and then compared for accuracy.
2.2. Stage 2. Classification of Outcome Measures According to the Five Main ICF Components
ICF linking rules were used in this study. These rules have been developed specifically to link the
content of each outcome measure to the ICF framework [22]. The rules suggest that meaningful concepts
within the items of outcome measures should be identified and then linked to the most precise ICF
category. Meaningful “concepts” are those that describe health condition, person, functional activity or
any of the environmental factors. For example, the measure IES-R scale (Impact of Event Scale–Revised)
has two items, “I had trouble staying asleep” and “I felt angry”, the concepts extracted from these
items were sleep and anger. Sleep was linked to the second level ICF category, “b134-sleep function”,
and anger was linked to the third level ICF category, “b1522-anger”. Meaningful concepts referring to
“quality of life” are assigned to the “not definable—quality of life” category. If a meaningful concept is
not contained in the ICF and is clearly a personal factor, it is assigned “personal factor”. If a meaningful
concept is not contained in ICF and is not a personal factor, it is assigned “not covered”. If the
meaningful concept refers to a diagnosis or a health condition, it is assigned “health condition” [22].
Based on the above rules, meaningful concepts were extracted from the items of the identified
measures and linked to relevant ICF categories. Finally, each outcome measure was then classified
to belong to the ICF component that covered the majority of its constituent questions. For example,
the items of GHQ-12 were linked to the two ICF components, “body function and structures” and
“activities”, with the majority of questions linking to the ICF “body function and structures” component.
Hence, this outcome measure was classified as belonging to (or representing) ICF “body function and
structures”. This stage was undertaken by authors KP and MS and cross-checked for consensus by
NYS and NF.
Based on the spread of the these meaningful concepts, each outcome measure was classified into
one of the main individual ICF components [22], defined as follows:
• Body structure and body function: refers to anatomical structure or physiological function such as
those required for cognition, cardiovascular function, motor functions, pain or emotion.
• Activities: refers to the execution of tasks at an individual level.
• Participation: refers to the individual’s involvement in everyday life situations.
• Environmental factors: refer to physical, social and attitudinal factors in the person’s life and
society which hinder or facilitate the functioning of the individual.
• Personal factors: refers to characteristics that are unique to each individual such as age, gender,
ethnicity, personality, resilience or experiences.
This stage was undertaken independently by all authors and cross-checked for consensus.
3. Results
3.1. Stage 1. Study Selection
The search of four databases yielded 1528 studies. Out of these, 36 studies were finally included
in this review. The reasons for exclusion of studies at each stage are reported in Figure 1.
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Table 1. Cont.
Abbreviation Outcome Measure
MRC Muscle Power Medical Research Council Muscle Power
NMS Exam Neuromuscular Examination
6MWD 6-Minute Walking Distance
CPET Cardiopulmonary Exercise Testing
FIM Functional Independence Measure
SGRQ St George’s Respiratory Questionnaire
FIC Functional Impairment Checklist
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PSSS Perceived Social Support Scale
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SES Self-Esteem Scale
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Table 2. Outcome measures used in follow-up studies of coronavirus survivors.
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Mak et al.
(2009) [23] + + + +
Lam et al.
(2009) [24] + + + +
Perception of social
stigmatization and
medicolegal issues
Wu et al.
(2005) [25] + +
5-point scale measuring
perceived threat to life
Lee et al.
(2007) [26] + + + +
Lee et al.
(2019) [27] + + +
Zhang et al.
(2005) [28] + + + + +
Self-compiled stressor
questionnaire
Hong et al.
(2009) [29] + + + + + +
Liu et al.
(2020) [30] + + + + + +
Lam et al.
(2006) [31] + + + + +
Peng et al.
(2003) [18] +
Xie et al.
(2005) [32] +
HE et al.
(2005) [33] +
Ong et al.
(2004) [34] + +
Ng et al.
(2005) [35] +
Zheng et al.
(2005) [36] +
Hsu et al.
(2004) [37] + +
Gao et al.
(2006) [38] +
Zheng-Yu et
al. (2003) [39] +
Int. J. Environ. Res. Public Health 2020, 17, 6476 7 of 15
Table 2. Cont.
Outcome Measures Used in Follow-Up Studies of Coronavirus Survivors
St
ud
ie
s
PF
T
IE
S-
R
H
A
D
S
SC
ID
SD
S
SA
S
SC
L-
90
PS
S-
10
G
H
Q
-1
2
D
A
SS
PH
Q
-9
PT
SD
-S
S
C
FS
FS
S
M
R
C
Po
w
er
G
ri
p
St
re
ng
th
Sy
m
pt
om
s
N
M
S
Ex
am
O
cu
la
r
Ex
am
6M
W
D
C
PE
T
FI
M
SF
-3
6
SG
R
Q
FI
C SD
SS
PS
SS
SC
SQ
SE
S
EP
Q
O
th
er
s
Yun et al.
(2003) [40] +
Liu et al.
(2007) [41] +
Ong et al.
(2005) [42] + +
Zhang et al.
(2020) [43] +
Tsai et al.
(2004) [13] + +
Chen et al.
(2006) [10] +
Hui et al.
(2005) [9] + + +
Wong et al.
(2004) [44] +
Li et al. (2006)
[45] + + +
Park et al.
(2018) [12] + +
Chiang et al.
(2004) [46] +
Yin et al.
(2005) [47] +
Wu et al.
(2016) [48] +
Tansey et al.
(2007) [11] + + + +
Avendano et
al. (2003) [49] +
Isakbaeva et
al. (2004) [50] +
Klopfenstein
et al. (2020)
[51]
+
Hopkins et al.
(2020) [52] +
Yuen et al.
(2004) [53] +
“+” means that this outcome measure was investigated by the respective study.
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Table 3. Mapping of outcome measure themes to ICF category codes.
B
od
y
Fu
nc
ti
on
s
an
d
St
ru
ct
ur
e
A
ct
iv
it
y
Pa
rt
ic
ip
at
io
n
En
vi
ro
nm
en
t
Pe
rs
on
al
Fa
ct
or
s
*
IC
F
C
od
e
A
ss
es
sm
en
t
PF
T
IE
S-
R
H
A
D
S
SC
ID
SD
S
SA
S
SCL-90
PS
S-
10
GHQ-12
D
A
SS
PH
Q
-9
PT
SD
-S
S
C
FS
FS
S
M
R
C
Po
w
er
G
ri
p
St
re
ng
th
Sy
m
pt
om
s
N
eu
ro
Ex
am
O
cu
la
r
Ex
am
6M
W
D
C
PE
T
FI
M
SG
R
Q
FI
C
SD
SS
SF
-3
6
PS
SS
SC
SQ
,S
ES
,
EP
Q
,S
oc
ia
lS
up
po
rt
,
T
hr
ea
tt
o
Li
fe
b1263 Psychic stability +
b1266 Confidence +
b130 Energy and drivefunctions + + + +
b1302 Appetite +
b134 Sleep function + + + +
b144 Memory function
b152 Stress + + +
b152 Anxiety + + + + + +
b152 Depression + + + + + + + +
b152 Panic +
b152 Fear + +
b152 Concentrate + + + +
b1522 Anger +
b1603 Control of Thoughts +
b210 Seeing function +
b255 Smell function +
b265 Touch sensation +
b280 Sensation of Pain +
b440 Respiratory functions +
b455 Exercise tolerancefunctions + + + +
b4552 Fatiguability + + +
b460 Sensation ofrespiratory system + +
b730 Muscle powerfunctions + + +
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s220 Structure of eyeball +
d175 Solving Problems + + +
d177 Making decisions + +
d310
Communication with –
receiving – spoken
language
+
d330 Speaking
d450 Walking + + + +
d460 Moving around indifferent locations + +
d510 Washing oneself + + + + +
d520 Caring for body parts + + +
d530 Toileting + +
d540 Dressing + + +
d640 Doing housework + + + +
d710 Basic interpersonalinteraction + + +
d640 Formal Relationship +
d760 Family Relationship + +
d770 Intimate Relationship + +
d845 Work andemployment + +
d920 Recreation andLeisure + + + +
e310 Immediate family +
e320 Friends +
* Personal factors do not have second-level or third-level categories yet, “+” means that these ICF concepts were assessed by the item of the respective outcome measure [17].
Int. J. Environ. Res. Public Health 2020, 17, 6476 10 of 15
4. Discussion
Considering the widespread prevalence of COVID-19, the long-term complications of coronavirus
infection in survivors will increase healthcare utilization significantly in the coming months. Previous
outbreaks have shown that there is a broad spectrum of long-term complications of coronavirus
infection which spans across all of the ICF components, with prevalence of respiratory compromise,
exercise intolerance, psychological distress and reduced quality of life being considerably high several
months following infection [5]. Deficits in different components do not necessarily translate into each
other and there is no causal relationship between them [15]. The return of COVID-19 survivors to
pre-infection levels of activity and participation in society are influenced not only by the degree of
recovery from impairments in body structure and function but also by their personal and environmental
factors, which hinder or facilitate their return to previous societal roles [54]. Therefore, it is essential that
all future follow-up studies looking at COVID-19 survivors measure all aspects of the ICF framework.
This review assimilates the outcome measures used in all the follow-up studies conducted during
the present and past coronavirus outbreaks and classifies them according the ICF categories in order
to provide a conceptual framework for the selection of outcome measures for future COVID-19
follow-up studies.
All studies included in this review reported outcomes in terms of body structure and
function. The most commonly reported impairment in coronavirus survivors was respiratory
compromise [9–12,34–36,39,42–44,48,55], with mainly restrictive patterns of lung function abnormality
on pulmonary function testing. Neuromuscular impairment of muscle power and sensory function,
particularly in those admitted to intensive care units, have also been reported based on neurological
examination, MRC muscle power and grip strength measurements [13]. Long-term fatigue has also
been measured using FSS and CFQ and found to be prevalent at 6 months post-discharge [24,27].
Alongside physical impairment, psychological impairments have also been widely elaborated by
several studies. Prevalence of PTSD [23,24,26,27,29,38], depression [23,24,26,27] and anxiety [23,26]
have been found to be particularly high in this cohort of patients. These mental health outcomes
have been measured using a variety of scales. Outcome measures which were particularly useful in
measuring impairment in these individuals were IES-R, PHQ-9 and GHQ-12 as these were able to
capture the impact of psychological issues on a range of functions such as sleep, concentration, appetite
and energy. We believe that at least two outcome measures should be used to assess impairment in
body structure and function to address the physical and psychological impairment separately, such as
a combination of lung function test and a PTSD outcome measure.
Limitations in activity have been measured through 6-min walking distance [9,12,31,45] and
cardiopulmonary testing in the included studies [34]. Most of the studies report these to be reduced
following discharge, with gradual improvement at 6 months post-discharge. Participation has been
measured using SF-36, SGRQ and SDSS. These reflect several domains of self-care, domestic life,
interpersonal relationships, mobility, work and social life. Quality of life has been reported to be
considerably reduced in coronavirus survivors [11,29,31,42,56]. Despite having extensive impact on
the overall wellbeing of an individual, these tools have been measured by only a minority of studies
and should be measured consistently across all future follow-up studies in COVID-19 survivors.
We recommend at least one functional measure of activity, such as walking distance, and one to capture
participation and quality of life, such as SF-36, for future studies.
Environmental factors have not been explored adequately by the included studies. Only one study
measured these through the perceived social support scale [28]. None of the studies provided or reported
information regarding pulmonary rehabilitation, pharmacological interventions or psychological
support. As these interventions are also considered as environmental factors which could facilitate
the recovery of these impairments in survivors, reporting of such factors in COVID-19 patients is
also important. Attitudes of family and society members have also not been explored. Some of the
measures which have been used to measure environmental factors in other areas of health have been
the Craig Hospital Inventory of Environmental Factors (CHIEF), Environmental Factors Item Bank
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(EFIB), Facilitators and Barrier’s Survey/Mobility (FABS/M) and Home and Community Environment
Instrument (HACE). Future studies must aim to capture these factors along with family and carer
support available in their chosen environments. Funding for rehabilitation will also play an important
role in recovery for COVID-19 patients [57].
Personal factors which may play a role in recovery, such as coping styles, self-esteem, social stigma
and personality, have been measured using self-constructed scales by some studies [24]. Some of the
validated tools which have been used to measure such personal factors in other areas of health are the
Connor Davidson resilience scale [58] and Kessler 6 psychological distress scale [59]. Inclusion of these
measures could enable us to explore this domain further.
Through the use of the ICF framework, it is evident that, whilst impairments in body structure
and function and restrictions in activity and participation have been measured extensively using
standardized outcome measures, personal and environmental factors have only been measured in a
small number of studies. The measurement of these contextual factors using standardized measures is
essential as they have a major role to play in these individuals’ health and return to function.
Figure 2 describes our ICF framework approach for selecting outcome measures for future
studies looking at long-term outcomes after COVID-19 illness. Apart from the measures suggested
in this framework, other outcomes which could be used to measure environmental and personal
factors are the Connor Davidson resilience scale, Kessler 6 psychological distress scale, Craig Hospital
Inventory of Environmental Factors (CHIEF), Environmental Factors Item Bank (EFIB), Facilitators and
Barrier’s Survey/Mobility (FABS/M) and Home and Community Environment Instrument (HACE) [60].
We propose that at least five different outcome measures spanning across all five ICF components need
to be used in future follow-up studies.
It might be useful wherever possible for researchers to try to use the same outcome measures
that were used in previous studies as this allows comparability and pooling of results. We however
acknowledge that this might not be possible when there is a compelling case to use a measure that
serves the purpose of the study better. For example, EQ5D is better suited to capture the health
economics of the impact of the COVID-19 outbreak and researchers might opt to choose this over SF-36,
which was predominantly used as the quality of life measure in previous studies.
The aim of this review was merely to categorize the currently available outcome measures into
the ICF domains so that future researchers could pick an outcome measure corresponding to each
category in order to capture the entire breadth of the health condition. We do not intend to make
recommendations regarding specific outcome measures under each ICF domain that the reader should
use. This would require further exploration of the psychometric properties of each measure, which is
outside the scope of this paper. We only aim to provide a framework that one should keep in mind
when choosing the measures rather than providing recommendations on which specific measure to use.
In the 36 studies included in this review, there were 33 different outcome measures used at
follow-up. This makes comparison of results from studies using different measures difficult. In order to
be able to do so, these diverse measures need to be converted into a common framework. This would
most logically be done using the ICF, as it is the most commonly recognized international language of
functioning. Thus, categorizing the measures into such a framework would be useful for researchers
as it would identify the ICF categories that these authors found useful for their studies and inform
their choice for future studies.
The main limitation of this review is that we have only described the outcome measures which
have been used in the follow-up studies so far. This does not mean that outcome measures not used in
these included studies are not suitable for use in future studies. Moreover, our search strategy was not
designed to look for rehabilitation studies in coronavirus survivors. If these had been included in the
review, then the set of outcome measures included in this review might have been slightly different.
However, the aim of this review was to provide an ICF-based framework for the selection of outcome
measures which researchers and clinicians are recommended to use. They need not necessarily use the
same outcome measures as previous studies. For example, some researchers might prefer to use EQ5D
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instead of SF-36 for capturing quality of life. The rehabilitation community will be working hard in
the next few years to help COVID-19 survivors achieve the best possible outcomes. The selection of
outcome measures must be an essential first step rather than an afterthought in this process.
5. Conclusions
In conclusion, we are proposing an ICF-based framework to assist researchers in selecting outcome
measures for future follow-up studies of COVID-19 survivors. This review highlighted that most
studies so far placed greater emphasis on measuring body function impairments, limitations in activities
and restrictions in participation. ICF personal and environmental factors were not as comprehensively
covered and need to be included in COVID-19 follow-up studies. The individual ICF components are
not linearly related and therefore a combination of outcome measures that capture all the components
is recommended for a better understanding of the impact on survivors and planning interventions to
maximize functional return.
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